Walking away from heart risk: new study tests simple exercise in women
NCT ID NCT07555457
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a 10-week moderate-intensity walking program can improve aerobic fitness, body composition, cholesterol, and inflammation in women. Researchers will compare results between premenopausal and postmenopausal women. Thirty-two women will participate, walking three times per week in supervised sessions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- moderate-intensity intermittent walking training program
- What this could lead to
- If it works, this could show that a simple walking routine helps improve heart health and reduce inflammation in women before and after menopause.
- What could go wrong
- This is a small, early-stage trial with only 32 participants, so results may not apply to all women. The walking program may not lead to lasting changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 32 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
32 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 32 to 43 years (premenopausal, with regular menstrual cycles for at least 12 months) or 49 to 65 years (postmenopausal, with absence of menstruation for at least 12 months). Body mass index (BMI) \> 24.9 kg/m². * For the postmenopausal group: amenorrhea ≥ 12 months. * For the premenopausal group: regular menstrual cycles for at least 12 months. Exclusion Criteria: * Cardiovascular diseases (hypertension, heart failure). * Presence of metabolic or inflammatory disorders (e.g., uncontrolled diabetes, autoimmune diseases, active infections).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiometabolic health in premenopausal and postmenopausal women are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
High Institute of Sport and Physical Education of Kef, University of Jendouba
El Kef, Boulifa, 7100, Tunisia